{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:08:21Z","timestamp":1792397301142,"version":"4.4.0"},"reference-count":29,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T00:00:00Z","timestamp":1094515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die Thrombangiitis obliterans (TAO) ist eine Erkrankung, die durch eine segmentale, nicht\u2010arteriosklerotische Entz\u00fcndung der kleinen und mittleren Arterien und Venen charakterisiert ist. Die pathologischen vaskul\u00e4ren Ver\u00e4nderungen finden sich zumeist im Bereich der distalen Extremit\u00e4ten, selten sind auch die Gef\u00e4\u00dfe viszeraler Organe beteiligt. Betroffen sind vor allem junge m\u00e4nnliche Raucher, bei denen es infolge einer Gef\u00e4\u00dfisch\u00e4mie zur Ausbildung von Ulzerationen und Gangr\u00e4n der Zehen und Finger kommen kann. Die Diagnose wird aufgrund typischer klinischer Kriterien gestellt, sowie anhand von pathologischen Ver\u00e4nderungen, die sich angiographisch und histologisch nachweisen lassen. Die exakte \u00c4tiologie der TAO ist bis heute unklar, es besteht jedoch eine nachgewiesene Assoziation mit Tabakkonsum. In der aktuellen Literatur wird auch eine autoimmunologische Genese diskutiert, wobei das initiierende Antigen bislang nicht identifiziert werden konnte.<\/jats:p><jats:p>Grundlage der Therapie der TAO ist der vollst\u00e4ndige Verzicht auf jede Form des Tabakkonsums. Auf der Basis dieses Verzichtes kann eine medikament\u00f6se Therapie, beispielsweise mit repetitiver Gabe von Prostacyclin\u2010Analoga eingeleitet werden. Die Lebenserwartung der Patienten mit TAO ist unver\u00e4ndert gegen\u00fcber der Normalbev\u00f6lkerung, allerdings besteht bei einer Vielzahl der Patienten die Gefahr der Exulzeration mit nachfolgender Amputation.<\/jats:p>","DOI":"10.1046\/j.1439-0353.2004.04047.x","type":"journal-article","created":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T15:42:27Z","timestamp":1094571747000},"page":"827-832","source":"Crossref","is-referenced-by-count":9,"title":["Thrombangiitis obliterans: Eine \u00dcbersicht"],"prefix":"10.1111","volume":"2","author":[{"given":"Daniela","family":"Hoeft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Kroger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Grabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Dissemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,7]]},"reference":[{"key":"e_1_2_10_2_2","first-page":"202","article-title":"\u00dcber eine eigent\u00fcmliche Form von Endarteriitis und Endophlebitis mit Gangr\u00e4n des Fusses","volume":"23","author":"Winiwarter F","year":"1878","journal-title":"Arch Klein Chir"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-190810000-00011"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009213431207"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02015288"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s003800200023"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.2190\/AFM3-01XY-CYGA-PHMD"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s104-002-8035-2"},{"key":"e_1_2_10_9_2","first-page":"1080","article-title":"Thrombangiitis obliterans Buerger: Pathologisch\u2010anatomische Analyse von 53 F\u00e4llen","volume":"115","author":"Leu HJ","year":"1985","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/29.2.266"},{"key":"e_1_2_10_11_2","first-page":"527","article-title":"Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and major histocompatibility complex","volume":"111","author":"Papa MZ","year":"1992","journal-title":"Surgery"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6045.1165"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198305123081901"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejvs.2002.1869"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2003.01528.x"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526.30.3.189"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1078\/0065-1281-00621"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(98)00175-2"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1043180"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050051179"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-5884(96)80081-5"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-192908000-00009"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7967(03)00023-1"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90346-7"},{"key":"e_1_2_10_25_2","doi-asserted-by":"crossref","unstructured":"The European TAO Study Group. Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double\u2010blind randomised placebo\u2010controlled trial. Eur J Vasc Endovasc Surg 1998; 15: 300\u200a\u2013\u200a307.","DOI":"10.1016\/S1078-5884(98)80032-4"},{"key":"e_1_2_10_26_2","first-page":"228","article-title":"Arterial reconstruction in Buerger's disease: by\u2010pass to disease\u2010free collaterals","volume":"21","author":"Shindo S","year":"2002","journal-title":"Int Angiol"},{"key":"e_1_2_10_27_2","first-page":"54","article-title":"Intra\u2010arterial streptokinase as adjuvant therapy for complicated Buerger's disease: early trials","volume":"78","author":"Hussein EA","year":"1993","journal-title":"Int Surg"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331970105200605"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(98)70022-9"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2003.08.006"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1439-0353.2004.04047.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1439-0353.2004.04047.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:59:50Z","timestamp":1697187590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1439-0353.2004.04047.x"}},"subtitle":["Thromboangiitis obliterans: an overview"],"short-title":[],"issued":{"date-parts":[[2004,9,7]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1046\/j.1439-0353.2004.04047.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1439-0353.2004.04047.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,7]]}}}